These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 36575505)
1. Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial. Botson JK; Obermeyer K; LaMoreaux B; Zhao L; Weinblatt ME; Peterson J Arthritis Res Ther; 2022 Dec; 24(1):281. PubMed ID: 36575505 [TBL] [Abstract][Full Text] [Related]
2. A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study. Botson JK; Tesser JRP; Bennett R; Kenney HM; Peloso PM; Obermeyer K; Song Y; LaMoreaux B; Zhao L; Xin Y; Chamberlain J; Ramanathan S; Weinblatt ME; Peterson J Arthritis Res Ther; 2022 Aug; 24(1):208. PubMed ID: 36008814 [TBL] [Abstract][Full Text] [Related]
3. Monosodium urate crystal depletion and bone erosion remodeling during pegloticase treatment in patients with uncontrolled gout: Exploratory dual-energy computed tomography findings from MIRROR RCT. Dalbeth N; Botson J; Saag K; Kumar A; Padnick-Silver L; LaMoreaux B; Becce F Joint Bone Spine; 2024 Jul; 91(4):105715. PubMed ID: 38447697 [TBL] [Abstract][Full Text] [Related]
4. Community Practice Experiences with a Variety of Immunomodulatory Agents Co-Administered with Pegloticase for the Treatment of Uncontrolled Gout. Broadwell A; Albert JA; Padnick-Silver L; LaMoreaux B Rheumatol Ther; 2022 Dec; 9(6):1549-1558. PubMed ID: 36136270 [TBL] [Abstract][Full Text] [Related]
5. Intensive urate-lowering with pegloticase plus methotrexate co-therapy in uncontrolled gout patients with and without chronic kidney disease: A retrospective case series. Albert J; Broadwell A; Padnick-Silver L; Marder B; LaMoreaux B Medicine (Baltimore); 2024 Mar; 103(10):e37424. PubMed ID: 38457582 [TBL] [Abstract][Full Text] [Related]
6. Pegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR). Botson JK; Tesser JRP; Bennett R; Kenney HM; Peloso PM; Obermeyer K; LaMoreaux B; Weinblatt ME; Peterson J J Rheumatol; 2021 May; 48(5):767-774. PubMed ID: 32934137 [TBL] [Abstract][Full Text] [Related]
8. A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings. Botson JK; Saag K; Peterson J; Parikh N; Ong S; La D; LoCicero K; Obermeyer K; Xin Y; Chamberlain J; LaMoreaux B; Verma S; Sainati S; Grewal S; Majjhoo A; Tesser JRP; Weinblatt ME Arthritis Rheumatol; 2023 Feb; 75(2):293-304. PubMed ID: 36099211 [TBL] [Abstract][Full Text] [Related]
9. Pegloticase treatment of chronic refractory gout: Update on efficacy and safety. Schlesinger N; Lipsky PE Semin Arthritis Rheum; 2020 Jun; 50(3S):S31-S38. PubMed ID: 32620200 [TBL] [Abstract][Full Text] [Related]
10. Dual-energy CT assessment of rapid monosodium urate depletion and bone erosion remodelling during pegloticase plus methotrexate co-therapy. Dalbeth N; Becce F; Botson JK; Zhao L; Kumar A Rheumatology (Oxford); 2022 Nov; 61(12):4898-4904. PubMed ID: 35293984 [TBL] [Abstract][Full Text] [Related]
11. Interventions for tophi in gout. Sriranganathan MK; Vinik O; Bombardier C; Edwards CJ Cochrane Database Syst Rev; 2014 Oct; (10):CD010069. PubMed ID: 25330136 [TBL] [Abstract][Full Text] [Related]
12. Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study. Albert JA; Hosey T; LaMoreaux B Rheumatol Ther; 2020 Sep; 7(3):639-648. PubMed ID: 32720081 [TBL] [Abstract][Full Text] [Related]
13. Recapture and improved outcome of pegloticase response with methotrexate-A report of two cases and review of the literature. Bessen SY; Bessen MY; Yung CM Semin Arthritis Rheum; 2019 Aug; 49(1):56-61. PubMed ID: 30583886 [TBL] [Abstract][Full Text] [Related]
14. Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase. Mandell BF; Yeo AE; Lipsky PE Arthritis Res Ther; 2018 Dec; 20(1):286. PubMed ID: 30594229 [TBL] [Abstract][Full Text] [Related]